Publications by authors named "M Chiappa"

Claim this Profile
O
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas.
Federica Guffanti, Ilaria Mengoli, Francesca Ricci, Ludovica Perotti, Elena Capellini, Michela Chiappa

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma.
Serena Petrella, Marika Colombo, Mirko Marabese, Chiara Grasselli, Andrea Panfili, Michela Chiappa

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.
Michela Chiappa, Alessandra Decio, Luca Guarrera, Ilaria Mengoli, Anju Karki

Cell Death Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plan and Operations of the National Health and Nutrition Examination Survey, August 2021-August 2023.
Ana L Terry, Michele M Chiappa, Juliana McAllister, David A Woodwell, Jessica E Graber

Vital Health Stat 1· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background.
Michela Chiappa, Federica Guffanti, Chiara Grasselli, Nicolò Panini, Alessandro Corbelli

Int J Mol Sci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis